Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. CAR-T cells forge ahead, Novartis reorganizes. Nat Biotechnol 34, 1079–1081 (2016). https://doi.org/10.1038/nbt1116-1079
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1116-1079
- Springer Nature America, Inc.
This article is cited by
-
First approval in sight for Novartis' CAR-T therapy after panel vote
Nature Biotechnology (2017)
-
Epic $12 billion deal and FDA's approval raise CAR-T to new heights
Nature Biotechnology (2017)